US2009171071A1PendingUtilityA1
PYY Agonists and Uses Thereof
Est. expiryFeb 4, 2025(expired)· nominal 20-yr term from priority
A61P 5/48A61P 43/00A61P 3/04A61P 3/00A61K 38/00A61K 47/60C07K 14/575C07K 14/00A61K 38/16
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides PYY 3-36 variants and pegylated derivatives thereof and compositions and methods useful in the treatment of conditions modulated by an NPY Y2 receptor agonist.
Claims
exact text as granted — not AI-modified1 - 37 . (canceled)
38 . A polynucleotide encoding the polypeptide of SEQ ID NO:3 or SEQ ID NO:4.
39 . A monoclonal antibody that specifically binds to a polypeptide comprising the amino acid sequence as shown in SEQ ID NO:3 or SEQ ID NO:4.
40 . The monoclonal antibody of claim 39 , wherein said polypeptide is pegylated at the cysteine residue.Join the waitlist — get patent alerts
Track US2009171071A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.